| Abstrakt: |
A study conducted at University Hospital San Ignacio in Bogota, Colombia, examined the performance of hybrid closed-loop (HCL) and advanced hybrid closed-loop (AHCL) systems in hospitalized patients with type 1 diabetes. The study analyzed continuous glucose monitoring (CGM) metrics and found that patients using HCL/AHCL systems achieved a time in range (TIR) of 70-180 mg/dL of 70.8% during hospitalization. The overall TIR was 75.5%, with minimal time spent below the target range. Patients using AHCL with active SmartGuard (SG) had a higher TIR and shorter hospital stay compared to those using HCL with active Automated Mode (AM). No serious adverse events related to the devices were reported. The study concluded that HCL/AHCL systems can effectively maintain glycemic control in hospitalized patients with type 1 diabetes without increasing the risk of hypoglycemia. [Extracted from the article] |
